Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)

NCT01374750 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Sirolimus
DRUG: m-TOR inhibitor free

Sponsor

Seoul National University Hospital